Narcolepsy | India| PDF | PPT| Case Reports | Symptoms | Treatment

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Conferences

Relevant Topics

Narcolepsy

  • Share this page
  • Pathophysiology 
    Narcolepsy is a chronic disease of the central nervous system. Excessive daytime sleepiness (EDS) is the main symptom and is present in 100% of patients with narcolepsy. Other primary symptoms of narcolepsy include: loss of muscle tone (cataplexy), istorted perceptions (hypnagogic hallucinations), and inability to move or talk (sleep paralysis).

  • Statistics
    Narcoleptics with long sleep time had a similar disease course and similar frequencies of cataplexy, sleep paralysis, hallucinations, multiple sleep onset in REM periods, short mean sleep latencies,  narcoleptics with normal sleep time did. However, they had longer sleep time during 24 h, and higher sleep efficiency, lower Epworth Sleepiness Scale scores, and reported their naps were more often unrefreshing.

  • Treatment
    1.Stimulants. Drugs that stimulate the central nervous system- modafinil or armodafinil 2.Selective serotonin reuptake inhibitors (SSRIs) or serotonin and norepinephrine reuptake inhibitors (SNRIs)- fluoxetine 3. Tricyclic antidepressants- protriptyline, imipramine 4.Sodium oxybate Research needs to be focused in 2 directions: prevention of lead exposure during pregnancy , prevention of lead leaching from bones for all women of childbearing age.

 

High Impact List of Articles

Conference Proceedings
{"cc_re__cc_re__cc_by_4_0": ["an class=\"__cf_email__\" data-cfemail=\"473428242e262b1837282b2e332e24262b34242e07282a2e243428292b2e29226924282a\">[email&#160;protected]</span></a> </p>\n<p><span class=\"fa fa-phone\"></span>1-702-714-7001<span class=\"pding-lft\">Extn: 9042</span>\n</p>\n</div>\n</div>\n</div>\n</div>\n<div class=\"footer_wraper_btm py-3\">\n<div class=\"container\">\n<div class=\"row align-items-center\">\n<div class=\"col-12 col-sm-6\" style=\"margin-top:10px; color:#fff\">\n<p class=\"footerNav\">Content of this site is vailable under <a rel=\"nofollow\" href=\"https://creativecommons.org/licenses/by/4.0/\" target=\"_blank\" style=\"color:#FFF;\" title=\"click here\">&nbsp;Creative Commons Attribution 4.0 License</a><br> Copyright &copy;\n2018 <a target=\"_blank\" title=\"OMICS International\" href=\"https://www.omicsonline.com/\" class=\"footer_links\">OMICS International</a> All Rights Reserved.</p>\n</div>\n<div class=\"col-12 col-sm-6\">\n<nav class=\"nav social-icons justify-content-end\">\n<a target=\"_blank\" title=\"Sitemap\" class=\"nav-link bg-warning fas fa-sitemap\" href=\"https://www.omicsonline.org/sitemap.xml\"></a>\n<a target=\"_blank\" title=\"slideshare\" class=\"nav-lin"], "copyright__copyright__copyright": ["ulants. Drugs that stimulate the central nervous system- modafinil or armodafinil 2.Selective serotonin reuptake inhibitors (SSRIs) or serotonin and norepinephrine reuptake inhibitors (SNRIs)- fluoxetine 3. Tricyclic antidepressants- protriptyline, imipramine 4.Sodium oxybate Research needs to be focused in 2 directions: prevention of lead exposure during pregnancy , prevention of lead leaching from bones for all women of childbearing age.\n\n\u00a0\n\nHigh Impact List of Articles\n\nConference Proceedings"]}